Evidence map›Paper›PMID 17218151›Full record

ArticleComputational biology and chemistry2007

A mathematical analysis of SELEX.

Howard A Levine, Marit Nilsen-Hamilton

Abstract read
In one paragraph

Article in Computational biology and chemistry, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Inside the Black Box: What Makes SELEX Better?Molecules (Basel, Switzerland) · 2019
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. The Genetic Code and RNA-Amino Acid Affinities.Life (Basel, Switzerland) · 2017
    Review
  15. Article
  16. Controlling uncertainty in aptamer selection.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  17. Aptamers in analytics.The Analyst · 2016
    Review
  18. Article
  19. Article
  20. Aptamers as both drugs and drug-carriers.BioMed research international · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Howard A LevineDepartment of Mathematics, Iowa State University, Ames, IA 50011, United States. halevine@iastate.edu
Marit Nilsen-Hamilton

Funding

Aptamers for Imaging and TherapyR42CA110222 · NCI · MOLECULAR EXPRESS, INC. · PI HAMILTON, RICHARD T · 2004 to 2009
$1.4M
NCI NIH HHS R42 CA110222NCI NIH HHS R42 CA110222-01
6 · The paper itself

Abstract

Systematic evolution of ligands by exponential enrichment (SELEX) is a procedure by which a mixture of nucleic acids that vary in sequence can be separated into pure components with the goal of isolating those with specific biochemical activities. The basic idea is to combine the mixture with a specific target molecule and then separate the target-NA complex from the resulting reaction. The target-NA complex is then separated by mechanical means (for example by filtration), the NA is then eluted from the complex, amplified by polymerase chain reaction (PCR) and the process repeated. After several rounds, one should be left with a pool of [NA] that consists mostly of the species in the original pool that best binds to the target. In Irvine et al. [Irvine, D., Tuerk, C., Gold, L., 1991. SELEXION, systematic evolution of nucleic acids by exponential enrichment with integrated optimization by non-linear analysis. J. Mol. Biol. 222, 739-761] a mathematical analysis of this process was given. In this paper we revisit Irvine et al. [Ibid]. By rewriting the equations for the SELEX process, we considerably reduce the labor of computing the round to round distribution of nucleic acid fractions. We also establish necessary and sufficient conditions for the SELEX process to converge to a pool consisting solely of the best binding nucleic acid to a fixed target in a manner that maximizes the percentage of bound target. The assumption is that there is a single nucleic acid binding site on the target that permits occupation by not more than one nucleic acid. We analyze the case for which there is no background loss (no support losses and no free [NA] left on the support). We then examine the case in which such there are such losses. The significance of the analysis is that it suggests an experimental approach for the SELEX process as defined in Irvine et al. [Ibid] to converge to a pool consisting of a single best binding nucleic acid without recourse to any a priori information about the nature of the binding constants or the distribution of the individual nucleic acid fragments.

Indexed as

Models, BiologicalLigandsMathematicsNonlinear DynamicsNucleic AcidsProtein BindingProteinsSELEX Aptamer TechniqueLigandsNucleic AcidsProteins

Identifiers

PMID17218151
PMCPMC2374838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.